Savant Capital LLC boosted its stake in CIGNA Co. (NYSE:CI) by 45.9% during the second quarter, Holdings Channel reports. The firm owned 2,290 shares of the health services provider’s stock after buying an additional 720 shares during the period. Savant Capital LLC’s holdings in CIGNA were worth $383,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Trillium Asset Management LLC boosted its stake in shares of CIGNA by 2.7% in the second quarter. Trillium Asset Management LLC now owns 160,414 shares of the health services provider’s stock worth $26,852,000 after buying an additional 4,272 shares during the period. Teacher Retirement System of Texas boosted its stake in shares of CIGNA by 4.7% in the second quarter. Teacher Retirement System of Texas now owns 478,064 shares of the health services provider’s stock worth $80,023,000 after buying an additional 21,472 shares during the period. First Trust Advisors LP boosted its stake in shares of CIGNA by 1.1% in the second quarter. First Trust Advisors LP now owns 117,015 shares of the health services provider’s stock worth $19,587,000 after buying an additional 1,261 shares during the period. Schwab Charles Investment Management Inc. boosted its stake in shares of CIGNA by 3.1% in the second quarter. Schwab Charles Investment Management Inc. now owns 867,183 shares of the health services provider’s stock worth $145,158,000 after buying an additional 26,244 shares during the period. Finally, Wetherby Asset Management Inc. boosted its stake in shares of CIGNA by 0.8% in the second quarter. Wetherby Asset Management Inc. now owns 4,192 shares of the health services provider’s stock worth $702,000 after buying an additional 33 shares during the period. 87.61% of the stock is owned by institutional investors and hedge funds.

CIGNA Co. (NYSE CI) opened at 176.35 on Tuesday. The firm has a market capitalization of $44.40 billion, a price-to-earnings ratio of 20.35 and a beta of 0.46. CIGNA Co. has a 52 week low of $115.03 and a 52 week high of $178.57. The stock’s 50 day moving average is $172.41 and its 200-day moving average is $159.55.

CIGNA (NYSE:CI) last issued its quarterly earnings data on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.48 by $0.43. The firm had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. CIGNA had a net margin of 7.85% and a return on equity of 22.67%. CIGNA’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period last year, the firm posted $1.98 EPS. On average, equities research analysts expect that CIGNA Co. will post $10.03 EPS for the current year.

WARNING: This report was first posted by Watch List News and is the property of of Watch List News. If you are reading this report on another website, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this report can be viewed at https://www.watchlistnews.com/cigna-co-ci-stake-raised-by-savant-capital-llc/1490394.html.

A number of brokerages recently weighed in on CI. Jefferies Group LLC reissued a “buy” rating and issued a $190.00 price target (down from $199.00) on shares of CIGNA in a research report on Friday, August 4th. Zacks Investment Research cut shares of CIGNA from a “buy” rating to a “hold” rating in a research report on Tuesday, August 8th. Royal Bank Of Canada reissued a “buy” rating and issued a $185.00 price target on shares of CIGNA in a research report on Wednesday, August 9th. ValuEngine cut shares of CIGNA from a “buy” rating to a “hold” rating in a research report on Thursday, July 20th. Finally, BidaskClub cut shares of CIGNA from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Three research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $180.06.

In related news, VP Mary T. Hoeltzel sold 500 shares of CIGNA stock in a transaction dated Tuesday, June 6th. The shares were sold at an average price of $166.70, for a total value of $83,350.00. Following the sale, the vice president now directly owns 2,449 shares in the company, valued at approximately $408,248.30. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO David Cordani sold 153,168 shares of CIGNA stock in a transaction dated Monday, June 19th. The shares were sold at an average price of $170.20, for a total transaction of $26,069,193.60. Following the completion of the sale, the chief executive officer now owns 421,162 shares in the company, valued at $71,681,772.40. The disclosure for this sale can be found here. Over the last quarter, insiders sold 261,539 shares of company stock worth $44,527,348. 1.30% of the stock is currently owned by insiders.

About CIGNA

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.